Anjali M. Bhorade
Research Subjects
Anjali M. Bhorade has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bradley Wilson
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri
2 shared publications - Mae O. Gordon
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri
2 shared publications Bradley S. Wilson
1 shared publication- David Brian Carr
Department of Medicine and Neurology, Washington University School of Medicine, St Louis, Missouri
1 shared publication - Jamie Kambarian
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, Missouri
1 shared publication Mae O. Gordon
1 shared publication
Latest Publications
- 1 June 2016
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 166, 43-51
On-road Driving Performance of Patients With Bilateral Moderate and Advanced Glaucoma
- 1 June 2016
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 166, 43-51
On-road Driving Performance of Patients With Bilateral Moderate and Advanced Glaucoma
- Open Access
- 1 December 2013
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 131 (12) , 1554-1562
Differences in Vision Between Clinic and Home and the Effect of Lighting in Older Adults With and Without Glaucoma
Clinicians often assume that vision measured in the clinic is equivalent to vision at home. However, many patients report visual difficulties greater than expected based on their vision testing in the clinic. Measurement disparities between clinical and nonclinical settings have been reported for blood pressure1,2 and cognitive function.3 Differences in vision measured in the clinic and home may also exist and partially explain the discord between patient report and clinical testing.
- 1 December 2013
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 131 (12) , 1554-1562
Open AccessDifferences in Vision Between Clinic and Home and the Effect of Lighting in Older Adults With and Without Glaucoma
Clinicians often assume that vision measured in the clinic is equivalent to vision at home. However, many patients report visual difficulties greater than expected based on their vision testing in the clinic. Measurement disparities between clinical and nonclinical settings have been reported for blood pressure1,2 and cognitive function.3 Differences in vision measured in the clinic and home may also exist and partially explain the discord between patient report and clinical testing.
- Open Access
- 14 March 2011
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 129 (3) , 276-281
Effect of Measurement Order Between Right and Left Eyes on Intraocular Pressure Measurement
Research from JAMA Ophthalmology — Effect of Measurement Order Between Right and Left Eyes on Intraocular Pressure Measurement
- 14 March 2011
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 129 (3) , 276-281
Open AccessEffect of Measurement Order Between Right and Left Eyes on Intraocular Pressure Measurement
Research from JAMA Ophthalmology — Effect of Measurement Order Between Right and Left Eyes on Intraocular Pressure Measurement
- 1 March 2009
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 20 (2) , 104-109
The monocular trial controversy: a critical review
The utility of the monocular trial to determine the response to topical ocular hypotensive medications has been recently debated. This review provides a critical evaluation of recent studies and discusses factors that affect the accurate determination of medication response. Recent concerns about the validity of the monocular trial arise from studies reporting a low-to-moderate correlation of intraocular pressure (IOP) response between the first and second eyes to the same topical ocular hypotensive medication. Few studies, however, have addressed the classic monocular trial that adjusts IOP in the trial eye based on IOP change in the fellow eye. Conflicting results from prior studies are due to differences in study question, study design, and method of analysis. Factors such as variability of IOP, diurnal variation, and regression to the mean further complicate the understanding of whether monocular trials or binocular simultaneous trials (i.e. testing each eye separately) are better for determining medication effect. The issue of whether or not to use the monocular trial remains controversial. A more clear understanding of factors such as nontherapeutic variability of IOP within the same eye and between eyes may elucidate the answer to this question. Further studies of monocular and binocular trials are needed to clarify which method better estimates medication response.
- 1 March 2009
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 20 (2) , 104-109
The monocular trial controversy: a critical review
The utility of the monocular trial to determine the response to topical ocular hypotensive medications has been recently debated. This review provides a critical evaluation of recent studies and discusses factors that affect the accurate determination of medication response. Recent concerns about the validity of the monocular trial arise from studies reporting a low-to-moderate correlation of intraocular pressure (IOP) response between the first and second eyes to the same topical ocular hypotensive medication. Few studies, however, have addressed the classic monocular trial that adjusts IOP in the trial eye based on IOP change in the fellow eye. Conflicting results from prior studies are due to differences in study question, study design, and method of analysis. Factors such as variability of IOP, diurnal variation, and regression to the mean further complicate the understanding of whether monocular trials or binocular simultaneous trials (i.e. testing each eye separately) are better for determining medication effect. The issue of whether or not to use the monocular trial remains controversial. A more clear understanding of factors such as nontherapeutic variability of IOP within the same eye and between eyes may elucidate the answer to this question. Further studies of monocular and binocular trials are needed to clarify which method better estimates medication response.